Tuesday, 10 February 2015

FDA Audit Practices: the 10 Most Commonly Cited Drug GMP Deficiencies of 2012-2013

ads

COO, VTS Consultants, Inc.



If there is one word within the life science industries that causes concern and anguish it is “audit.” As with any evaluation process, the success of getting through a regulatory audit is a combination of preparedness with regards to what to expect, knowing the current regulations that apply to your product and knowing what tends to be the areas of deficiencies in audits  performed. All of these items can be researched on the web and the time and effort to review and provide training on them will serve companies well.

READ MORE »

FDA Audit Practices: the 10 Most Commonly Cited Drug GMP Deficiencies of 2012-2013 Rating: 4.5 Diposkan Oleh: Unknown

 

Top